Evidence map›Paper›PMID 34500834›Full record

ArticleMolecules (Basel, Switzerland)2021

Biflavonoids from

Fenghua Kang, Sha Zhang, Dekun Chen, Jianbing Tan, Min Kuang, Jinlin Zhang, Guangyuan Zeng, Kangping Xu, Zhenxing Zou, Guishan Tan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 16 citations in OpenAlex.

  1. Advances in the Anti-Tumor Activity of Biflavonoids inInternational journal of molecular sciences · 2023
    Review
  2. Article
  3. A novel biflavone fromFrontiers in pharmacology · 2022
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Fenghua KangXiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China.
Sha ZhangXiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China.
Dekun ChenXiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China.
Jianbing TanXiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China.
Min KuangXiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China.
Jinlin ZhangXiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China.
Guangyuan ZengXiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China.
Kangping XuXiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China.
Zhenxing ZouXiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China.
Guishan TanXiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China.
Central South University · CNXiangya Hospital Central South University · CN

Funding

High-tech Industry Science and Technology Innovation Project of Hunan Province 2020GK4083National Natural Science Foundation of China No. 31700303
6 · The paper itself

Abstract

Four new biflavonoids (

Indexed as

A549 CellsAntineoplastic AgentsApoptosisBiflavonoidsCarcinoma, Non-Small-Cell LungCell CycleHumansLung NeoplasmsSelaginellaceaeAntineoplastic AgentsBiflavonoidsantiproliferative activityapoptosisbiflavonoidcell cycleSelaginella doederleinii

Identifiers

PMID34500834
PMCPMC8434134
OpenAlexW3197344038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.